Advertisement

Neurological Sciences

, Volume 40, Issue 2, pp 377–384 | Cite as

Influential factors and clinical significance of an atypical presentation of posterior reversible encephalopathy syndrome in patients with eclampsia

  • Xiaoyu Dong
  • Jianfei NaoEmail author
Original Article
  • 76 Downloads

Abstract

Background and purpose

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiologic entity for which eclampsia is one of the most common predisposing conditions. Despite the imaging changes typically reported, the predisposing factors and clinical implications of atypical presentations have yet to be fully clarified.

Methods

A total of 56 patients with PRES were selected for study. Demographic, clinical, and laboratory data were analyzed, focusing on atypical presentations of PRES. Multiple logistic regression was applied to identify factors impacting such atypical presentations, and functional outcomes were assessed upon patient discharge.

Results

Overall, 22 of the 56 patients (39.3%) displayed features of atypical PRES. By multiple logistic regression, headache (OR = 5.39; 95% CI, 1.24–23.51; p = 0.025) and frequent convulsions (OR = 4.41; 95% CI, 1.09–17.91; p = 0.038) proved to be independent factors associated with atypical PRES. Ultimately, outcomes of 18 patients were gauged as poor, based on the modified Rankin Scale (mRS). Logistic regression indicated that visual disturbances (OR = 9.02; 95% CI, 1.37–59.35; p = 0.02), frequent convulsions (OR = 9.47; 95% CI, 1.67–53.63; p = 0.01), and restricted diffusion on imaging (OR = 11.96; 95% CI, 1.76–81.11; p = 0.01) were independently associated with poor outcomes in patients with eclampsia-related PRES.

Conclusion

Headache and frequent convulsions are independently associated with atypical presentations of PRES. If present, restricted diffusion may help in predicting poor outcomes of such patients upon discharge.

Keywords

Posterior reversible encephalopathy syndrome MRI Eclampsia Restricted diffusion 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This study conformed to Ethical Guidelines for Medical and Health Research Involving Human Subjects endorsed by the Chinese government and was authorized by the Ethics Committee of Shengjing Hospital at China Medical University.

References

  1. 1.
    Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500.  https://doi.org/10.1056/nejm199602223340803 CrossRefPubMedGoogle Scholar
  2. 2.
    Fugate JE, Rabistein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14(9):914-925CrossRefGoogle Scholar
  3. 3.
    Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol 28(7):1320–1327.  https://doi.org/10.3174/ajnr.A0549 CrossRefPubMedGoogle Scholar
  4. 4.
    Chen Z, Xu M, Shang D, Luo B (2012) A case of reversible splenial lesions in late postpartum preeclampsia. Intern Med 51(7):787–790.  https://doi.org/10.2169/internalmedicine.51.6500 CrossRefPubMedGoogle Scholar
  5. 5.
    Benziada-Boudour A, Schmitt E, Kremer S, Foscolo S, Riviere AS, Tisserand M, Boudour A, Bracard S (2009) Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images. J Neuroradiol 36(2):102–105.  https://doi.org/10.1016/j.neurad.2008.08.003 CrossRefPubMedGoogle Scholar
  6. 6.
    Ishikura K, Hamasaki Y, Sakai T, Hataya H, Goto T, Miyama S, Kono T, Honda M (2011) Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol 15(2):275–280.  https://doi.org/10.1007/s10157-010-0380-2 CrossRefPubMedGoogle Scholar
  7. 7.
    Pande AR, Ando K, Ishikura R, Nagami Y, Takada Y, Wada A, Watanabe Y, Miki Y, Uchino A, Nakao N (2006) Clinicoradiological factors influencing the reversibility of posterior reversible encephalopathy syndrome: a multicenter study. Radiat Med 24(10):659–668.  https://doi.org/10.1007/s11604-006-0086-2 CrossRefPubMedGoogle Scholar
  8. 8.
    Li Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J (2012) Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J Stroke Cerebrovasc Dis 21(8):873–882.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.05.010 CrossRefPubMedGoogle Scholar
  9. 9.
    Wagner SJ, Acquah LA, Lindell EP, Craici IM, Wingo MT, Rose CH, White WM, August P, Garovic VD (2011) Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc 86(9):851–856.  https://doi.org/10.4065/mcp.2011.0090 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol 29(6):1043–1049.  https://doi.org/10.3174/ajnr.A0929 CrossRefPubMedGoogle Scholar
  11. 11.
    Hod T, Cerdeira AS, Karumanchi SA (2015) Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med 5(10).  https://doi.org/10.1101/cshperspect.a023473
  12. 12.
    Liman TG, Bohner G, Heuschmann PU, Scheel M, Endres M, Siebert E (2012) Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases. Eur J Neurol 19(7):935–943.  https://doi.org/10.1111/j.1468-1331.2011.03629.x CrossRefPubMedGoogle Scholar
  13. 13.
    Karampekios SK, Contopoulou E, Basta M, Tzagournissakis M, Gourtsoyiannis N (2004) Hypertensive encephalopathy with predominant brain stem involvement: MRI findings. J Hum Hypertens 18(2):133–134.  https://doi.org/10.1038/sj.jhh.1001654 CrossRefPubMedGoogle Scholar
  14. 14.
    Chen TY, Lee HJ, Wu TC, Tsui YK (2009) MR imaging findings of medulla oblongata involvement in posterior reversible encephalopathy syndrome secondary to hypertension. Am J Neuroradiol 30(4):755–757.  https://doi.org/10.3174/ajnr.A1337 CrossRefPubMedGoogle Scholar
  15. 15.
    Ekawa Y, Shiota M, Tobiume T, Shimaoka M, Tsuritani M, Kotani Y, Mizuno Y, Hoshiai H (2012) Reversible posterior leukoencephalopathy syndrome accompanying eclampsia: correct diagnosis using preoperative MRI. Tohoku J Exp Med 226(1):55–58.  https://doi.org/10.1620/tjem.226.55 CrossRefPubMedGoogle Scholar
  16. 16.
    Tari Capone F, Candela S, Bozzao A, Orzi F (2015) A new case of brainstem variant of posterior reversible encephalopathy syndrome: clinical and radiological features. Neurol Sci 36(7):1263–1265.  https://doi.org/10.1007/s10072-014-1999-7 CrossRefPubMedGoogle Scholar
  17. 17.
    Hinduja A, Habetz K, Raina S, Ramakrishnaiah R, Fitzgerald RT (2017) Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int J Neurosci 127(2):135–144.  https://doi.org/10.3109/00207454.2016.1152966 CrossRefPubMedGoogle Scholar
  18. 18.
    Golombeck SK, Wessig C, Monoranu C-M, Schutz A, Solymosi L, Melzer N, Kleinschnitz C (2013) Fatal atypical reversible posterior leukoencephalopathy syndrome: a case report. J Med Case Rep 7:14–14.  https://doi.org/10.1186/1752-1947-7-14 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    O'Kane M, Elhalwagy H, Kumar S, Badawi C (2014) Unusual presentation of PRES in the postnatal period. BMJ Case Rep.  https://doi.org/10.1136/bcr-2013-203406
  20. 20.
    Li Q, Lv F, Wei Y, Yan B, Xie P (2013) Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone. Neurol Sci 34(12):2241–2242.  https://doi.org/10.1007/s10072-013-1479-5 CrossRefPubMedGoogle Scholar
  21. 21.
    American College of O, Gynecologists, Task Force on Hypertension in P (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Obstet Gynecol 122(5):1122–1131.  https://doi.org/10.1097/01.aog.0000437382.03963.88 CrossRefGoogle Scholar
  22. 22.
    Porcello Marrone LC, Marrone BF, Gadonski G, Huf Marrone AC, da Costa JC (2012) Posterior reversible encephalopathy syndrome. Clin Adv Hematol Oncol 10(9):614–615PubMedGoogle Scholar
  23. 23.
    Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A (2017) Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology 59(4):379–386.  https://doi.org/10.1007/s00234-017-1815-1 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Singh RR, Ozyilmaz N, Waller S, U-King-Im J-M, Lim M, Siddiqui A, Sinha MD (2014) A study on clinical and radiological features and outcome in patients with posterior reversible encephalopathy syndrome (PRES). Eur J Pediatr 173(9):1225–1231.  https://doi.org/10.1007/s00431-014-2301-y CrossRefPubMedGoogle Scholar
  25. 25.
    Provenzale JM, Petrella JR, Cruz LCH, Wong JC, Engelter S, Barboriak DP (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. Am J Neuroradiol 22(8):1455–1461PubMedGoogle Scholar
  26. 26.
    McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 189(4):904–912.  https://doi.org/10.2214/ajr.07.2024 CrossRefGoogle Scholar
  27. 27.
    Aracki-Trenkic A, Stojanov D, Trenkic M, Radovanovic Z, Ignjatovic J, Ristic S, Trenkic-Bozinovic M (2016) Atypical presentation of posterior reversible encephalopathy syndrome: clinical and radiological characteristics in eclamptic patients. Bosn J Basic Med Sci 16(3):180–186.  https://doi.org/10.17305/bjbms.2016.1201 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Bloch RF (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19(11):1448–1448CrossRefGoogle Scholar
  29. 29.
    Tavares M, Arantes M, Chacim S, Campos Junior A, Pinto A, Mariz JM, Sonin T, Pereira S (2015) Posterior reversible encephalopathy syndrome in children with hematologic malignancies. J Child Neurol 30(12):1669–1675.  https://doi.org/10.1177/0883073815578525 CrossRefPubMedGoogle Scholar
  30. 30.
    Alp A, Akdam H, Akar H, Koseoglu K, Ozkul A, Meteoglu I, Yenicerioglu Y (2014) Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report. Nefrologia 34(6):789–796.  https://doi.org/10.3265/Nefrologia.pre2014.Sep.12510 CrossRefPubMedGoogle Scholar
  31. 31.
    Zhao B, Wei Q, Wang Y, Chen Y, Shang H (2014) Posterior reversible encephalopathy syndrome in acute intermittent porphyria. Pediatr Neurol 51(3):457–460.  https://doi.org/10.1016/j.pediatrneurol.2014.05.016 CrossRefPubMedGoogle Scholar
  32. 32.
    Lin JT, Wang SJ, Fuh JL, Hsiao LT, Lirng JF, Chen PM (2003) Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. Am J Neuroradiol 24(1):102–104PubMedGoogle Scholar
  33. 33.
    Rykken JB, McKinney AM (2014) Posterior reversible encephalopathy syndrome. Seminars In Ultrasound Ct And Mri 35(2):118–135.  https://doi.org/10.1053/j.sult.2013.09.007 CrossRefGoogle Scholar
  34. 34.
    Donmez FY, Basaran C, Ulu EMK, Yildirim M, Coskun M (2010) MRI features of posterior reversible encephalopathy syndrome in 33 patients. J Neuroimaging 20(1):22–28.  https://doi.org/10.1111/j.1552-6569.2008.00306.x CrossRefPubMedGoogle Scholar
  35. 35.
    Kastrup O, Schlamann M, Moenninghoff C, Forsting M, Goericke S (2015) Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns. Clin Neuroradiol 25(2):161–171.  https://doi.org/10.1007/s00062-014-0293-7 CrossRefPubMedGoogle Scholar
  36. 36.
    Bartynski WS, Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. Am J Neuroradiol 29(3):447–455.  https://doi.org/10.3174/ajnr.A0839 CrossRefPubMedGoogle Scholar
  37. 37.
    Stevens CJ, Heran MKS (2012) The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 85(1020):1566–1575.  https://doi.org/10.1259/bjr/25273221 CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    de Groot PG, Urbanus RT, Roest M (2012) Platelet interaction with the vessel wall. Handb Exp Pharmacol 210:87–110.  https://doi.org/10.1007/978-3-642-29423-5_4 CrossRefGoogle Scholar
  39. 39.
    Shankar J, Banfield J (2017) Posterior reversible encephalopathy syndrome: a review. Can Assoc Radiol J 68(2):147–153.  https://doi.org/10.1016/j.carj.2016.08.005 CrossRefPubMedGoogle Scholar
  40. 40.
    Sibai BM (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105(2):402–410.  https://doi.org/10.1097/01.aog.0000152351.13671.99 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurologyShengjing Hospital of China Medical UniversityShenyangPeople’s Republic of China

Personalised recommendations